Scholars Central

CommentaryPublished 28 Aug 2023

Clinical Trial of Novel Cancer Treatment Show Increased Survival Rates

Annals of Clinical Trials and Vaccines Research

Volume 13 · Issue 4 · Pages 112–114

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The field of clinical research is continually advancing, seeking new and improved treatments for various medical conditions. Phase 3 clinical trials play a pivotal role in evaluating the safety and efficacy of potential therapeutics before they can be approved for widespread use. In this article, we delve into a groundbreaking Phase 3 clinical trial that holds the promise of revolutionizing the treatment of a specific disease or condition. In the early stages of drug development, Phase 1 and Phase 2 clinical trials help researchers understand the safety profile and preliminary efficacy of the investigational drug or therapy. Once a candidate has shown promising results in these initial phases, it progresses to a Phase 3 clinical trial – the largest and most comprehensive stage of testing. During this phase, the investigational therapy is compared to existing treatments or a placebo to validate its effectiveness, safety, and tolerability on a larger scale. The Phase 3 clinical trial discussed in this article is a multi-center, randomized, double-blind, placebo-controlled study involving a substantial number of participants. The trial aims to investigate the potential benefits and risks of the new therapeutic in a real-world setting, closely mirroring the conditions under which it will be used if approved for commercialization.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Annals of Clinical Trials and Vaccines Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAnnals of Clinical Trials and Vaccines Research
  • SubjectPharmaceutical Sciences
  • SubjectVaccines & Immunisation